Last reviewed · How we verify
NCT05690412: PaNETh
Efficacy and Safety of Endoscopic Papillectomy in the Treatment of Ampullary Neoplasms.
trial testing Endoscopic Papillectomy in Ampullary Adenoma in 400 participants. Status unknown.
31 March 2023
Quick facts
| Lead sponsor | Azienda Unità Sanitaria Locale della Romagna |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 400 |
| Start date | 1 April 2022 |
| Primary completion | 31 March 2023 |
| Estimated completion | 31 March 2023 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Endoscopic Papillectomy
Conditions studied
- Ampullary Adenoma — all drugs for Ampullary Adenoma →
- Ampulla of Vater Adenoma — all drugs for Ampulla of Vater Adenoma →
- Ampullary Cancer — all drugs for Ampullary Cancer →
- Ampulla of Vater Cancer — all drugs for Ampulla of Vater Cancer →
Sponsor
Azienda Unità Sanitaria Locale della Romagna
Who can join
18 and older, any sex, with Ampullary Adenoma or Ampulla of Vater Adenoma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of our study is to provide data on the efficacy and safety of endoscopic papillectomy, by including consecutive patients treated after 2015, when first guidelines on endoscopic management of ampullary neoplasms were available.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05690412
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Endoscopic Papillectomy
Trials testing the same drug.
- NCT05028465 — EP Combined With RFA for Ampullary Neoplasms With Intraductal Biliary Extension · NA · completed
- NCT03494543 — Endoscopic Papillectomy for Ampullary Adenomas · completed
Other recruiting trials for Ampullary Adenoma
Currently open trials in the same condition.
- NCT06435767 — Quantitative Nodal Burden as a Determinant Identifying Ampullary Adenocarcinoma Patients Benefiting From Adjuvant Chemot · recruiting
Other Azienda Unità Sanitaria Locale della Romagna trials
Trials by the same sponsor.
- NCT05913453 — Technical Failure During Colorectal Endoscopic Full Thickness Resection (EFTR): The "Through Thick and Thin" Study · completed
- NCT06115564 — Microbiological Assessment of Bile in Patients Undergone to Endoscopic Retrograde Cholangiography (ERCP): the "Microbile · unknown
- NCT05395013 — Efficacy and Safety of Plastic, Covered and Uncovered Self-expandable Metal Stents in the Treatment of Malignant Biliary · completed
- NCT06965036 — Risk Factors and Outcomes of Ischemic Stroke Associated With Tandem or Isolated Cervical Artery Occlusion in Anterior an · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05690412 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Azienda Unità Sanitaria Locale della Romagna
- Last refreshed: 23 January 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05690412.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing